Cortina Asset Management’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | $5.01M | Sell |
70,402
-593
| -0.8% | -$42.2K | 0.31% | 137 |
|
|
2019
Q1 | $5.57M | Buy |
70,995
+5,929
| +9% | +$465K | 0.35% | 119 |
|
|
2018
Q4 | $5.51M | Buy |
65,066
+32,370
| +99% | +$2.74M | 0.34% | 112 |
|
|
2018
Q3 | $5.6M | Sell |
32,696
-23,710
| -42% | -$4.06M | 0.26% | 144 |
|
|
2018
Q2 | $7.29M | Buy |
56,406
+5,671
| +11% | +$733K | 0.34% | 100 |
|
|
2018
Q1 | $5.23M | Sell |
50,735
-6,838
| -12% | -$704K | 0.26% | 149 |
|
|
2017
Q4 | $4.92M | Sell |
57,573
-14,777
| -20% | -$1.26M | 0.22% | 179 |
|
|
2017
Q3 | $6.15M | Sell |
72,350
-35,093
| -33% | -$2.98M | 0.25% | 143 |
|
|
2017
Q2 | $8.14M | Buy |
107,443
+25,595
| +31% | +$1.94M | 0.34% | 88 |
|
|
2017
Q1 | $5.4M | Buy |
+81,848
| New | +$5.4M | 0.22% | 162 |
|
|
2015
Q3 | – | Sell |
-130,720
| Closed | -$8.23M | – | 242 |
|
|
2015
Q2 | $8.23M | Sell |
130,720
-31,481
| -19% | -$1.98M | 0.36% | 123 |
|
|
2015
Q1 | $7.8M | Buy |
+162,201
| New | +$7.8M | 0.34% | 121 |
|